LEUPRORELINE Sandoz 3 mois implant 5 mg ser pré
7680571410014
CH-57141
L02AE02
07.16.2.
1 / 3
google
Details
- Product number
- 5714101
- CPT
- -
- Packaging group
- 1 x 1
- Unit
- Spritze(n)
- Composition
- leuprorelinum 5 mg ut leuprorelini acetas, acidum polylacticum pro praeparatione.
Articles (1)
Leuprorelin Sandoz 3 Monate, Fertigspritze mit Implantat
Fertigspritze
1 x 1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 284.50
Specialties list
Yes
Generic
No
SL addition date:
01/09/2008
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 57141
- Drug name
- Leuprorelin Sandoz 3 Monate, Fertigspritze mit Implantat
- Galenic form
- IMPF
- ATC Code
- L02AE02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 23/07/2008
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LEUPRORELINE Sandoz 3 mois implant 5 mg ser pré
- Description (DE)
- LEUPRORELIN Sandoz 3 Monate Implant 5 mg Fertspr
- Market launch
- 23/07/2008
- Narcotic (BTM)
- No